Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter IntfiledCriticalBaxter Int
Priority claimed from PCT/US1995/008151external-prioritypatent/WO1996001611A1/en
Publication of MXPA97000148ApublicationCriticalpatent/MXPA97000148A/en
Publication of MX9700148ApublicationCriticalpatent/MX9700148A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Prostheses
(AREA)
Abstract
An implantable device for the prevention or treatment of cancer comprising an implantable chamber containing tumor cells, or somatic cells engineered to express at least one antigen corresponding to antigen of a patient's tumor; the chamber having a porous wall to provide, in use, a porous boundary between the patient's immune cells and the contained cells; the porosity of the boundary being sufficient to permit subcellular antigenic material to pass through the boundary, while preventing the contained cells and patient immune cells from passing through the boundary.
MX9700148A1995-06-051995-06-29Implanted device containing tumor cells for the treatment of cancer.
MX9700148A
(en)
Therapeutic aplication of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma